Merih Güray DURAK, Pınar BALCI, Süleyman Özkan AKSOY, Ali İbrahim SEVİNÇ

Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?

Background/aim: Phyllodes tumors (PTs) of the breast are rare, and their diagnosis and treatment remain controversial. Thisretrospective study aims to examine the clinical outcome of benign and borderline PTs, according to the surgical margins.Materials and methods: We examined the medical records of 122 patients in our clinic, who had histologically confirmed benign andborderline PTs between 1994 and 2017.Results: The mean age of the patients was 40.6 years (range 18.0–81.0, ±12.1 standard deviation [SD]) and the mean tumor size was 25.8mm (range 9–65, ±10.3 SD). All patients underwent a breast-conserving procedure and the median follow-up was 51 months. Tumormargins were positive (tumor touching the ink) in 43 patients (35%). Only 16 patients (13%) had margins ≥10 mm. The margins werebetween 2 and 10 mm in most patients (40%) and ≤1 mm in 12% of the patients.Conclusion: Although no re-excision was performed to obtain grossly clear margins, local recurrence was not observed in any patients.Therefore, revision surgery for close or positive surgical margins for benign and borderline PTs should not be performed as a rule. Asmost tumors recur within 2 years of diagnosis, we propose a close clinical and imaging follow-up during this period.

PDF

___

Dyer NH, Bridger JE, Taylor RS. Cystosarcoma phylloides. Br J Surg 1966; 53: 450-455.
Buchanan EB. Cystosarcoma phyllodes and its surgical management. Am Surg 1995; 61: 350-355.
Muller J. Uber den Feineren Ban und Die Formen der Krankaften Geschwulste. Vol. 1. Berlin, Germany: Greiner, 1838 (in German).
World Health Organization. The World Health Organization histological typing of breast tumors—second edition. Am J Clin Pathol 1982; 78: 806-816.
Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL. Phylloides tumor of the breast: the challenge persists. World J Surg 2006; 30: 1414-1421.
Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multiinstitutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 2009; 16: 2288- 2294.
Tse GMK, Niu Y, Shi HJ. Phyllodes tumor of the breast: an update. Breast Cancer 2010; 17: 29-34.
Duman L, Gezer NS, Balcı P, Altay C, Başara I, Durak MG, Sevinç AI. Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care 2016; 11: 123-127.
August AD, Kearney T. Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation. Surg Oncol 2000; 9: 49-52.
Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumor of the breast. J Clin Pathol 2006; 59: 454-459.
Bhargav PR, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK. Phyllodes tumor of the breast: clinicopathological analyses of recurrent vs. non-recurrent cases. Asian J Surg 2009; 32: 224-228.
Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Lıu CL, Lıu TP. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005; 91: 185- 194.
Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y, Wang X, Mao J, Shen X. Imaging findings in phyllodes tumors of the breast. Eur J Radiol 2012; 81: e62-69.
Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V et al. Phyllodes tumors of the breast: a consensus review. Histopathology 2016; 68: 5-21.
Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 2015; 22: 2912-2918.
Ward ST, Jewkes AJ, Jones BG, Chaudri S, Hejmadi RK, Ismail T, Hallissey MT. The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumors of the breast. Int J Surg 2012; 10: 527-531.
Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Lae M, Bollet M, Pierga JY, Salmon R, Fitoussi A. Management of phyllodes breast tumors. Breast J 2011; 17: 129-137.
Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PWT, Pollock RE, Hunt KK. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89: 1502-1511.
Reinfuss M, Mitus J, Stelmach A, Rys J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analyses of 170 cases. Cancer 1996; 77: 910-916.
Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumors of the breast. Eur J Surg Oncol 2001; 27: 723- 730.
Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil S et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 2007; 14: 2961-2970.
Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 2012; 19: 2612-2617.
Onekendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of the resection and tumor characteristics on patient outcome. Ann Surg Oncol 2014; 21: 3304-3309.
Kim S, Kim JY, Kim DH, Jung WH, Koo JS. Analyses of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat 2013; 141: 353-363.
Zurrida S, Bartoli C, Galimberti V, de Palo G, Squicciarini P, Delledone V, Salvadori B, Veronesi P, Bono A. Which therapy for unexpected phyllode tumor of the breast? Eur J Cancer 1992; 28: 654-657.
Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY. Recurrent phyllodes tumors of the breast: pathological features and clinical implications. ANZ J Surg 2006; 76: 476- 480.
Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol 2007; 37: 730- 736.